D-0223-2018 Class III Terminated

Recalled by Hetero Labs, Ltd. - Unit III — Hyderabad, N/A

FDA drug recall D-0223-2018 was initiated by Hetero Labs, Ltd. - Unit III on Dec 22, 2017 and is designated Class III. Reason for recall: Presence of foreign substance: metallic razor blade was found in one bottle. The recall status is terminated (terminated Mar 23, 2018).

Recall details

Product Type
Drugs
Report Date
Jan 24, 2018
Initiation Date
Dec 22, 2017
Termination Date
Mar 23, 2018
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Simvastatin Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured by: Hetero (trademark), Hetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India, NDC 31722-513-10

Reason for recall

Presence of foreign substance: metallic razor blade was found in one bottle.

Distribution pattern

U.S.A. nationwide

Code information

Lot #: E171280, Exp 06/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0223-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0223-2018. Report a data issue: hello@regdatalab.com.